Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Autoimmune Diseases × Mastectomy, Segmental × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 57 Rectal Neoplasms 9 Triple Negative Breast Neoplasms 8 Carcinoma, Intraductal, Noninfiltrating 6 Adenocarcinoma of Lung 5 Carcinoma, Non-Small-Cell Lung 4 Breast Carcinoma In Situ 4 Pancreatic Neoplasms 2 Lung Neoplasms 2 Unilateral Breast Neoplasms 1 Recurrence 1 Patient Satisfaction 1 Pain, Postoperative 1 Neoplastic Cells, Circulating 1 Neoplasm Micrometastasis 1 Margins of Excision 1 Lymphedema 1 Local Recurrence of Malignant Tumor of Breast 1 Inflammatory Breast Neoplasms 1 Chordoma 1 Carcinoma, Lobular 1 Carcinoma, Ductal, Breast 1 Carcinoma, Ductal 1 Breast Image Scale Index for Self Esteem Evaluation 1 BRCA1/2 Mutation 1 Autoimmune Diseases 1 Anatomic Stage II Breast Cancer AJCC v8 1 Amenorrhea 1

Interventions

telitacicept 3 Prednisone 3 Data Collection 3 fludarabine 2 Specimen Handling 2 Nivolumab 2 Cyclophosphamide 2 Blood Specimen Collection 2 Antilymphocyte Serum 2 thymoglobulin 1 remdesivir 1 prednylidene 1 human papillomavirus vaccine, L1 type 16, 18 1 deltacortene 1 carmustine, poliferprosan 20 drug combination 1 apremilast 1 Watchful Waiting 1 Vitamin D 1 Valsartan 1 Surveys and Questionnaires 1 Standard of Care 1 Pyridostigmine Bromide 1 Practice Guidelines as Topic 1 Population Groups 1 Plasma Exchange 1 Phlebotomy 1 Peripheral Blood Stem Cell Transplantation 1 Music Therapy 1 Methods 1 Melphalan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05400954 2023-04-28

AREOLA-B

The Netherlands Cancer Institute

15,000 enrolled

Autoimmune Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡